Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-060568

Director sold 755 shares at $44.94 ($33,930)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Salter Malcolm Director 2021-10-15 Sale −755 $44.94 $33,930 12,462 D
Open-market sales · 755 sh · avg $44.94 · $33,930
Loading xslF345X03/doc4.xml…